10-69572545-C-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000242462.5(NEUROG3):c.499G>A(p.Gly167Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0423 in 1,608,162 control chromosomes in the GnomAD database, including 1,672 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
ENST00000242462.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NEUROG3 | NM_020999.4 | c.499G>A | p.Gly167Arg | missense_variant | 2/2 | ENST00000242462.5 | NP_066279.2 | |
NEUROG3 | XM_017016280.2 | c.499G>A | p.Gly167Arg | missense_variant | 2/2 | XP_016871769.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NEUROG3 | ENST00000242462.5 | c.499G>A | p.Gly167Arg | missense_variant | 2/2 | 1 | NM_020999.4 | ENSP00000242462 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0334 AC: 5081AN: 152148Hom.: 122 Cov.: 33
GnomAD3 exomes AF: 0.0373 AC: 8718AN: 233760Hom.: 195 AF XY: 0.0393 AC XY: 5025AN XY: 127762
GnomAD4 exome AF: 0.0433 AC: 62996AN: 1455896Hom.: 1550 Cov.: 37 AF XY: 0.0436 AC XY: 31586AN XY: 723888
GnomAD4 genome AF: 0.0333 AC: 5075AN: 152266Hom.: 122 Cov.: 33 AF XY: 0.0323 AC XY: 2404AN XY: 74460
ClinVar
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Mar 27, 2013 | - - |
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at